John Mascola
59Patents
5h-index
155Co-inventors
71Inventor score
Filing activity: Sep 6, 2006 → Apr 26, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8637036B2 | Neutralizing antibodies to HIV-1 and their use | Chemistry; Metallurgy | 14 | Active |
| US10301377B2 | Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use | Physics | 11 | Active |
| US9695230B2 | Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein | Chemistry; Metallurgy | 7 | Active |
| US10035844B2 | Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope protein | Chemistry; Metallurgy | 6 | Active |
| US10961283B2 | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens | Chemistry; Metallurgy | 6 | Active |
| US10363301B2 | Stabilized influenza hemagglutinin stem region trimers and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US9175070B2 | Neutralizing antibodies to HIV-1 and their use | Chemistry; Metallurgy | 3 | Active |
| US10400015B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 3 | Active |
| US10004800B2 | Antibody evolution immunogens | Chemistry; Metallurgy | 3 | Active |
| US9403763B2 | CD4-mimetic inhibitors of HIV-1 entry and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11370828B2 | Anti-coronavirus antibodies and methods of use | Physics | 3 | Active |
| US9738703B2 | Neutralizing antibodies to HIV-1 and their use | Chemistry; Metallurgy | 2 | Active |
| US9475862B2 | Neutralizing GP41 antibodies and their use | Physics | 2 | Active |
| US10035845B2 | Neutralizing antibodies to HIV-1 and their use | Chemistry; Metallurgy | 2 | Active |
| US11459360B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 2 | Active |
| US8268323B2 | Conformationally stabilized HIV envelope immunogens | Chemistry; Metallurgy | 1 | Active |
| US10898566B2 | Zika virus vaccines | Emerging Cross-Sectional Technologies | 1 | Active |
| US11338033B2 | Stabilized group 2 influenza hemagglutinin stem region trimers and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10562960B2 | Neutralizing antibodies to gp120 and their use | Physics | 1 | Active |
| US11174292B2 | Substitutions-modified prefusion RSV F proteins and their use | Chemistry; Metallurgy | 1 | Active |
| US11939356B2 | Self-assembling insect ferritin nanoparticles | Chemistry; Metallurgy | 1 | Active |
| US11878998B2 | Prefusion RSV F proteins and their use | Chemistry; Metallurgy | 1 | Active |
| US11890339B2 | Nipah virus immunogens and their use | Chemistry; Metallurgy | 1 | Active |
| US12145968B2 | Recombinant HIV-1 envelope proteins and their use | Physics | 0 | Active |
| US11679151B2 | Stabilized influenza hemagglutinin stem region trimers and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.